Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
SUZHOU, China, ROCKVILLE, Md. and SAN FRANCISCO, July 20, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines...
Inteleos and Kenya Women and Children’s Wellness Center Partner to Reduce Maternal and Fetal Mortality
Partnership aims to address United Nations Sustainable Development Goal 3.1 ROCKVILLE, Md., July 19, 2022 /PRNewswire/ -- Inteleos™, a non-profit global healthcare certification organization, and the Kenya Women and Children's Wellness Center (KWCWC) signed a memorandum of understanding to reduce maternal and fetal morbidity and mortality in Kenya by providing comprehensive ultrasound training and certification programs that match Kenyan clinical...
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, July 19, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appointment of Samuel Zhang, Ph.D., as its...
PeriGen Applauded by Frost & Sullivan for Its Innovative Perinatal Software Solutions for Fetal Monitoring and Clinical Decision Support
PeriGen's perinatal information systems provide the most accurate and holistic approach for monitoring infant and maternal health, enhancing clinical efficiency, allowing timely intervention, and promoting standardized care. SAN ANTONIO, July 19, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the maternal and infant care solutions industry and, based on its analysis, recognizes PeriGen...
ZAGENO Applauded by Frost & Sullivan for Simplifying the Supply Chain for Life Science Research with Its e-Commerce Platform
The Life Science Research e-Commerce platform enables researchers to make the best purchasing decisions for their experiments, expedite procurement processes, and advance research. SAN ANTONIO, July 19, 2022 /PRNewswire/ -- Recently, Frost & Sullivan assessed the life sciences e-commerce industry, and, based on its findings, recognizes ZAGENO with the 2022 Customer Value Leadership Award. The company provides a life science...
Seegene launches world’s first In-life PCR campaign in Vietnam
Test center LabHouse and ride-hailing service Grab to start PCR testing for Grab drivers in August Seegene to provide Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay to simultaneously detect COVID-19, flu, cold Testing to begin with drivers in Ho Chi Minh, Hanoi and will later be expanded to other cities "Aimed at countering COVID-19...
Oncoshot Enters Collaboration Agreement With Omico (Australian Genomic Cancer Medicine Centre)
SINGAPORE, July 19, 2022 /PRNewswire/ – Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented at the event yesterday by Dr Huren Sivaraj, CEO and co-founder of Oncoshot, and Prof David Thomas, CEO of Omico and head of Genomic Cancer Medicine at the Garvan Institute. The event...
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore
This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore, including a research and development service center and large-scale drug substance and drug product manufacturing facilities for biologics The investment strengthens WuXi Biologics' global research, development and manufacturing network with more robust nodes to meet the growing demand from clients worldwide for end-to-end services, and continues...
Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene’s Best-in-Class Bispecific Antibody with Celularity’s Natural Killer Cell Platform
- This research collaboration marks Antengene's entry into the field of cellular medicines. SHANGHAI and HONG KONGJuly 19, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that it has...
WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation
SINGAPORE, July 19, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry, today announced a plan to build a new R&D and manufacturing site in Singapore. The company intends to invest up to S$2 billion (approximately US$1.43 billion) to construct and operationalize the site, which aims to...
